ArticleKorean journal of radiology2022

Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible.

Josef FinstererPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.